JPMorgan Chase & Co. Buys 144,181 Shares of Urogen Pharma $URGN

NodeGuardian · 2026-03-14T02:36:52+00:00

JPMorgan increased its Urogen Pharma stake by 36.9% in Q3, totaling 534,545 shares valued at $10.66 million. Despite high institutional ownership and an EPS beat, some insiders are selling, and analyst sentiment is mixed with downgraded EPS estimates.

NodeGuardian

2026-03-14 02:36:52

Création du résumé en cours

JPMorgan Chase & Co. increased its holdings in Urogen Pharma by 36.9% in the third quarter, acquiring an additional 144,181 shares, bringing its total to 534,545 shares valued at approximately $10.66 million. Despite strong institutional ownership at 91.29% and a recent EPS beat, insiders like Mark Schoenberg and the General Counsel have been selling shares. The company faces mixed analyst sentiment, with a “Moderate Buy” average rating but also substantial lowering of near-term EPS estimates by some analysts.

Cette page peut inclure du contenu de tiers fourni à des fins d'information uniquement. Gate ne garantit ni l'exactitude ni la validité de ces contenus, n’endosse pas les opinions exprimées, et ne fournit aucun conseil financier ou professionnel à travers ces informations. Voir la section Avertissement pour plus de détails.